Trial intelligence / Profile preview

BoNT-A effects on ankle joint resistance in spasticity

NL-OMON26235Recruiting

Sponsor
Sint Maartenskliniek
Start
Aug 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of botulinum toxin type A in Muscle spasm, sponsored by Sint Maartenskliniek. Primary endpoint: Reflexive joint resistance. Started Aug 2020; status: recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

Muscle spasm

Beyond the preview

Go deeper on NL-OMON26235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call